How the treatment of AML will change
Mary Frances McMullin
What are the alternative treatment options for relapsed or elderly AML patients?
When to use bispecifics for AML
Re-analysis of RESONATE-2 trial of ibrutinib vs chlorambucil in CLL
What is the focus of lymphoma research in 2017?